文献速递中药与中成药合理使用中医内科

开口箭水提物体外及小鼠模型抗单纯疱疹病毒1型活性研究

Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N. Tanaka aqueous extracts.
PubMed 文献 · J Ethnopharmacol · 2025-05-22

本研究解析开口箭水提物(RCAE)化学成分,并在细胞和小鼠模型中评估其抗HSV-1活性及机制。RCAE对Vero细胞EC50为7.994 μg/mL,可直接杀灭病毒、抑制黏附、减轻皮肤炎症并抑制潜伏再激活,机制可能与抑制病毒糖蛋白gD及增强树突状细胞和CD8+ T细胞免疫有关。

要点

  • RCAE在Vero细胞中抗HSV-1的EC50为7.994 μg/mL。
  • RCAE可直接杀灭HSV-1并抑制病毒黏附(30 μg/mL,P<0.001)。
  • RCAE可能通过抑制gD功能及调节免疫发挥多靶点抗HSV-1作用。

核心结论

  • RCAE在临床前模型中具有直接杀病毒、抑制复制、免疫调节和抑制HSV-1潜伏再激活的多靶点抗病毒作用。
  • RCAE的抗HSV-1作用可能与其抑制病毒糖蛋白gD功能相关。

研究设计与样本

  • 采用UPLC-Q-TOF-MS/MS表征RCAE化学成分,鉴定出9个主要化合物。
  • 体外实验包括直接杀病毒试验、HSV-1黏附抑制试验及HSV-1潜伏再激活模型。
  • 体内实验采用小鼠侧腹划痕HSV-1感染模型,并评估树突状细胞成熟、CD8+ T细胞分化及细胞因子表达。
  • 采用分子对接分析RCAE活性化合物与HSV-1 gD的相互作用。

主要发现

  • RCAE对Vero细胞抗HSV-1的EC50值为7.994 μg/mL。
  • 30 μg/mL RCAE处理组可直接杀灭HSV-1并抑制病毒黏附,与HSV-1组比较P<0.001。
  • 不同剂量RCAE处理组减轻HSV-1感染小鼠皮肤病毒感染和炎症,涉及NF-κB通路,与HSV-1组比较P<0.001。
  • 0.6 g/mL RCAE处理组对HSV-1感染小鼠脑和DRG的抗病毒感染作用与HSV-1组比较P<0.05。
  • 0.6 g/mL RCAE处理组促进小鼠DC成熟、CD8+ T细胞分化及CXCL1和IFN-γ分泌,并抑制HSV-1免疫逃逸,与HSV-1组比较P<0.05。

关键数值与推荐

  • RCAE对Vero细胞抗HSV-1的EC50为7.994 μg/mL。
  • 30 μg/mL RCAE处理组直接杀灭HSV-1和抑制黏附的效应与HSV-1组比较P<0.001。
  • 不同剂量RCAE处理组降低HSV-1感染小鼠皮肤gD基因表达及HaCaT细胞gD mRNA水平,与HSV-1组比较P<0.001。
  • 分子对接显示化合物9与HSV-1 gD结合能为-10.5 kcal/mol。

临床怎么用

  • RCAE成分复杂且未完全明确,目前仅限临床前研究,尚不能据此形成临床用药推荐。
  • 开口箭民间用于疱疹 simplex 感染,但需未来研究明确关键抗病毒成分及其体内效力和机制。

局限性

  • RCAE化学组成复杂且未完全明确。
  • 需未来研究识别关键抗病毒成分并验证其体内效力和机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Herpes simplex virus type 1 (HSV-1) is a prevalent neurotropic pathogen that establishes lifelong latency in the peripheral nervous system, posing substantial clinical challenges due to its recurrent infections and emerging drug resistance. Rohdea chinensis (Baker) N. Tanaka, a traditional Chinese herbal medicine, has been historically used for heat-clearing, detoxifying, wind-dampness dispelling, blood-stasis removing, and pain-relieving properties. Despite its common folk use in Leshan, Sichuan Province, for treating herpes simplex infections, the chemical composition and antiviral activity of Rohdea chinensis remain largely uninvestigated. AIM OF THE STUDY: The aim of this study was to clarify the chemical composition and antiviral activity of the Rohdea chinensis aqueous extract (RCAE), and preliminarily speculate the possible mechanism of its antiviral effect. MATERIALS AND METHODS: The chemical profile of RCAE was characterized using UPLC-Q-TOF-MS/MS, identifying 9 major compounds. The antiviral effects of RCAE were assessed through in vitro and in vivo models, including direct virucidal assays, HSV-1 adhesion inhibition, and a mouse model of flank scratch HSV-1 infection. Immunomodulatory effects were evaluated by analyzing dendritic cell (DC) maturation, CD8+ T cell differentiation, and cytokine expression. Additionally, HSV-1 latent reactivation models were established to assess RCAE's impact on viral persistence in the dorsal root ganglion (DRG). Molecular docking studies were conducted to determine potential interactions between RCAE bioactive compounds and HSV-1 glycoprotein D (gD). RESULTS: The overall anti-HSV-1 effect of RCAE on Vero cells was determined and the EC50 value was 7.994 μg/mL. RCAE directly killed HSV-1 and inhibited HSV-1 adhesion in vitro (P < 0.001, 30 μg/mL RCAE treated groups vs HSV-1 group), and alleviated viral infection and inflammation of the skin involving the NF-κB pathway (P < 0.001, different doses of RCAE treated groups vs HSV-1 group), as well as anti-viral infection of the brain and DRG in HSV-1-induced mice (P < 0.05, 0.6 g/mL RCAE treated groups vs HSV-1 group). Interestingly, RCAE played an antiviral role by increasing the maturation of DC in mice, enhancing the antigen presentation ability of DC, promoting the differentiation of CD8+T cells and the secretion of CXCL1 and IFN-γ, and inhibiting the immune escape of HSV-1 virus (P < 0.05, 0.6 g/mL RCAE treated groups vs HSV-1 group). Besides, RCAE prevented the reactivation of HSV-1 in vitro (P < 0.001, 0.6 g/mL RCAE treated groups vs HSV-1 group). HSV gD is a critical viral glycoprotein that plays a central role in viral attachment to host cells, intercellular spread, and entry into host cells. To clarify the anti-HSV-1 mechanism of RCAE, molecular docking was employed to preliminarily confirm stable interactions between RCAE compounds (notably compound 9, with a binding energy of -10.5 kcal/mol) and HSV-1 gD. In vitro and in vivo experiments showed that RCAE reduced the expression of gD gene (P < 0.001, different doses of RCAE treated groups vs HSV-1 group) and protein in skin tissues of HSV-1-infected mice, as well as the gD mRNA levels (P < 0.001, different doses of RCAE treated groups vs HSV-1 group) in HSV-1-treated HaCaT cells. These findings suggest that the anti-HSV-1 effect of RCAE may be associated with the inhibition of gD function. CONCLUSIONS: Our results indicate that RCAE has multi-target antiviral effects, including direct virus-killing activity, inhibition of viral replication, immune regulation, and inhibition of latent reactivation of HSV-1 in preclinical models. Integrating traditional Chinese medicine principles (heat-clearing, detoxifying, and blood-stasis-removing properties) with modern pharmacological activities (antiviral, anti-inflammatory, and immunomodulatory effects), RCAE demonstrates potential as a natural product candidate for addressing HSV-1 infection. Given RCAE's complex and undefined composition, future studies are needed to identify key antiviral components and their in vivo efficacy and mechanisms.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Jiang H, Yang H, Li H, et al. Anti-herpes simplex virus type 1 activity of the Rohdea chinensis (Baker) N. Tanaka aqueous extracts. J Ethnopharmacol. 2025. PMID: 40412773. doi:10.1016/j.jep.2025.120024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。